50
Participants
Start Date
September 30, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
October 31, 2015
Paclitaxel
80 mg/m2 IV over 60 minutes weekly for 12 weeks
Eribulin
1.4 mg/m2 IV over 2 to 5 minutes on Days 1 and 8 every 21 days for 4 cycles
Doxorubicin
60 mg/m2 IV over 15 minutes on day 1 every 21 days for 4 cycles
Cyclophosphamide
600 mg/m2 IV over 30 minutes on day 1 every 21 days for 4 cycles
Allegheny General Hospital/Allegheny-Singer Research Institute, Pittsburgh
NSABP Foundation, Inc., Pittsburgh
Albert Einstein Medical Center, Philadelphia
Mary Babb Randolph Cancer Center at West Virginia University Hospitals, Morgantown
Wake Forest University Health Sciences, Winston-Salem
Carolinas Medical Center/Levine Cancer Center, Charlotte
Roper Hospital, Charleston
Cancer Centers of the Carolinas, Greenville
Memorial Health University Medical Center, Savannah
Phoebe Putney Memorial Hospital, Albany
CCOP - Mount Sinai Medical Center, Miami Beach
Henry Ford Health System, Detroit
West Michigan Cancer Center, Kalamazoo
Joe Arrington Cancer Research & Treatment Center, Lubbock
CCOP, Colorado Cancer Research Program, Inc., Denver
Providence Hospital - Southfield, Southfield
Cancer Institute of New Jersey, New Brunswick
University of Pittsburgh, Pittsburgh
Centre Hospitalier de l'Universite de Montreal, Montreal
Montreal General Hospital, Montreal
Eisai Inc.
INDUSTRY
NSABP Foundation Inc
NETWORK